INTRODUCTION
============

Recent genome-wide studies have identified many mono-allelically expressed genes among mammalian genomes ([@B1; @B2; @B3; @B4; @B5]). Mono-allelically expressed genes are those primarily expressed from one allele, and the choice of the allele is determined in a stochastic or parent-of-origin-specific manner. In the mouse genome, more than one hundred autosomal genes exhibit parent-of-origin-specific gene expression, the so-called imprinted genes. The expression of imprinted genes is primarily governed by the imprint control element (ICE), which shows differential DNA methylation status between two parental alleles.

Non-coding antisense transcription is thought to regulate mono-allelic gene expression because it is frequently observed at imprinted gene loci; 15% of imprinted murine genes are associated with the antisense transcript ([@B6]). One of the best-known examples of an antisense transcript arising from an imprinted gene locus is *Air*, which is paternally transcribed from the antisense strand of *Igf2r* and represses expression of neighboring genes on the same chromosome ([@B7]). *Kcnq1ot1* is another paternally expressed antisense transcript, and it suppresses the surrounding imprinted domain controlled by KvDMR ([@B8]). Antisense transcripts arising from other imprinted genes have been reported ([@B9; @B10; @B11; @B12; @B13]), but their function is not known. Some antisense transcripts arise from imprinted loci spanning 100--1000 kb, suggesting that antisense-mediated regulation of genomic imprinting is achieved in a locus-wide manner.

In order to fully understand the relationship between allele specificity and locus-wide competition between sense and antisense transcripts, we examined the gene locus of *Ube3a* (ubiquitin protein ligase E3A) whose orthologous partner, UBE3A, in human is known to cause Angelman syndrome, a neurogenetic disorder, when mutated ([@B14],[@B15]). *Ube3a* is expressed from the maternal allele specifically in brain, but is bi-allelically expressed in most other tissues. *Ube3a-ATS* (also known as *LNCAT*), an antisense counterpart of *Ube3a*, is also specifically expressed in the brain from a paternal allele ([@B16],[@B17]). Transcription of *Ube3a-ATS* spans a 1 Mb genomic region (≥460 kb in the case of the human genome), starting from alternative U-exons upstream of *Snurf*/*Snrpn* ([@B16]), and is detected only in neuronal cells concomitantly with maternal expression of *Ube3a*.

To examine the megabase-wide landscape of strand- and allele-specific transcriptional activity in the *Ube3a--Snurf*/*Snrpn* region, we exploited a highly parallel SNP genotyping platform---the Illumina GoldenGate Genotyping Assay---to target the transcriptome and to detect transcriptional output. This highly parallel SNP genotyping platform enables the simultaneous genotyping of hundreds of SNPs ([@B18],[@B19]). Here, we made custom-panels of GoldenGate Assay covering murine SNPs within the ≥1Mb *Ube3a--Snurf*/*Snrpn* region. We identified SNPs for the standard laboratory mouse strain, C57BL/6J (B6), and MSM/Ms (MSM), an inbred strain derived from the Japanese wild mouse (*Mus musculus molossinus*) ([@B20]). Commonly used inbred mouse strains are primarily derived from the *Mus musculus domesticus* subspecies, with some genomic contributions from *molossinus*, *musculus* and *castaneus* subspecies ([@B21]). Inbred strains derived from *molossinus* have a higher frequency of polymorphims than the standard laboratory mouse strains derived from *M. musculus domesticus*, when they are compared with the B6 reference genome. A high frequency of polymorphisms is necessary to examine allele-specific transcriptional activity at a high resolution.

MATERIALS AND METHODS
=====================

Computer-based detection of SNPs and genotyping experiments
-----------------------------------------------------------

We sequenced five MSM BAC clones (MSMg01-118E18, MSMg01-106D06, MSMg01-352C08, MSMg01-480H06 and MSMg01-407I16) covering the *Ube3a--Snurf*/*Snrpn* genomic region. BAC clones were selected according to the alignment between the BAC-end sequences ([@B22]) and the mouse genome assembly UCSC mm6 (NCBI build 34). Nucleotide sequence alignment between BAC sequences and the C57BL/6J reference genome, UCSC mm8 (NCBI build 36), identified 5698 candidate SNPs. Because the mm8 assembly has a large insertion within the *Ube3a--Snurf*/*Snrpn* intergenic region by comparison with the mm6 build, many intergenic SNPs might not be included in our list. A total of 2,304 SNPs were selected, and these candidate SNPs were validated by the Illumina GoldenGate Assay targeting genomic DNA from the mouse strains C57BL/6J, MSM, and their reciprocal crosses. A total of 1420 SNPs were selected for transcriptome-targeting analyses: 712 for detecting plus-strand expression and 708 for detecting minus-strand expression from the *Ube3a--Snurf* locus ([Supplementary Figure S1](http://nar.oxfordjournals.org/cgi/content/full/gkq1201/DC1)). Because Illumina GoldenGate Assay's allele-specific primer is designed for either strand of the genome sequence, one SNP site can only detect the transcriptional output from either strand, if the assay targets cDNA. Plus-strand denotes those that detect the expression from plus strand of the UCSC mouse genome assembly, whereas minus-strand indicates the expression from minus-strand.

Target preparation for the Illumina GoldenGate genotyping assay
---------------------------------------------------------------

Genomic DNA was isolated by the standard protocol. Briefly, the dissected tissues (kidney) were treated with proteinase K overnight at 55°C, and the genomic DNA was precipitated with ethanol after phenol/chloroform extraction. Isolated genomic DNA was subjected to the Illumina GoldenGate genotyping assay by following the manufacturer's procedures. For transcriptome-targeted assays, total RNA from brain and liver was isolated from 8- to 10-week-old C57BL/6J and MSM mice by using Trizol reagent (Invitrogen), and was reverse-transcribed by using random hexamers. The resultant cDNA was then subjected to the Illumina GoldenGate Assay.

Pre-processing of raw data
--------------------------

The signal intensity values from the Cy3 and Cy5 channels were subjected to loess normalization by using the limma package from R ([@B23]). The efficacy of two-color normalization in a transcriptome-targeted GoldenGate Assay has been described previously ([@B24]). Unsupervised thresholding based on the discriminant analysis method ([@B25]) was conducted for each Cy3 and Cy5 signal distribution to discriminate expressed/non-expressed SNP sites. When both the Cy3 and Cy5 signals were under the assigned threshold values, the SNP site was marked as non-expressed. The theta value \[(2/*π*)tan^−1^(*S*~M~/*S*~B~)\], where *S*~M~ and *S*~B~ denote signals representing MSM and B6 alleles, respectively ([@B19]), was then calculated for each SNP site to discriminate between the expressed allele type, i.e. B6 (\<0.15), MSM (0.82\<) or bi-allelic (intermediates). Threshold values were determined by the same method as for expressed/non-expressed SNP sites. The raw data were deposited in the NCBI GEO under accession number GSE21667.

Sequence analyses of the expressed alleles of *Ube3a* and *Ube3a-ATS*
---------------------------------------------------------------------

Total RNA from the brains of hybrid mice (BM and MB, 8- to 10-weeks old) was prepared by using Trizol reagent (Invitrogen) according to the manufacturer's protocol. RNA concentration was determined with a NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies). Total RNA (5 µg) was reverse transcribed with 50 U of Super Script^TM^ reverse transcriptase (Invitrogen) using specific forward and reverse primers. Strand-specific cDNA synthesis was performed by using reverse primers for the sense cDNA strand of *Ube3a* and forward primers for the antisense cDNA strand of *Ube3a*. The primer sequences were SNP-692, 5′-CCAACCATGAAAGGCTTGAAAT-3′ (forward) and 5′-TCCTACAAATTTCCTGGGCAAG-3′ (reverse); SNP-722, 5′-ATAAATTTGGGCGCCTGTCAAT-3′ (forward) and 5′-GAGGCATCACTGAACTAGCAAGG-3′ (reverse); SNP-G02, 5′-TAAGTATTAAGAAGACTGGAG-3′ (forward) and 5′-ACAGTGGAAGAAACAGGTCAC-3′; SNP-820, 5′-GGGCATTGGATCCTATTACAGA-3′ (forward) and 5′-GGAAACAGCAAAATCATCCTCA-3′ (reverse); SNP-933, 5′-ATCCTGCAGACTTGAAGAAGC-3′ (forward) and 5(′-ATCATACATCATTGGGTTACC-3′ (reverse); SNP-K19, 5′-TTCTGGTTTTCTCAAGTTCAG-3′ (forward) and 5′-AGATTTATTGAGAATGTAGTC-3′ (reverse). The forward and reverse primer pairs were used to amplify the cDNA products for 35 cycles. PCR products were extracted from agarose gels using the MinElute Gel Extraction Kit (Qiagen) and were then subjected to sequence analysis.

RESULTS
=======

Highly parallel genotyping of C57BL/6J and MSM/Ms
-------------------------------------------------

Prior to transcriptome-targeted SNP genotyping, we selected a set of measurable SNPs between C57BL/6J (B6) and MSM/Ms (MSM), by sequencing five MSM BAC clones covering *Ube3a--Snurf*/*Snrpn* genomic region and assayed 2304 candidate SNP sites with the Illumina GoldenGate Assay, targeting genomic DNA from B6, MSM, and the two reciprocal crosses. A total of 1420 validated SNPs were selected for transcriptome-targeted analyses ([Supplementary Figure S1](http://nar.oxfordjournals.org/cgi/content/full/gkq1201/DC1)). Most SNPs (82.3%) were located within the extra-genic region of *Ube3a* and *Snurf*/*Snrpn*, whereas five were exonic and 245 were intronic ([Figure 1](#F1){ref-type="fig"}A). Because of the unprocessed nascent-like nature of endogenous antisense transcripts ([@B26]), we generated cDNA targets by random hexamers priming and used for the assay. This cDNA targets should represent not only the poly(A)-plus--processed mRNAs but also the poly(A)-minus RNA population. The SNP frequency detected between B6 and MSM in the corresponding region is the highest among the combination of B6 and other mouse strains ([Figure 1](#F1){ref-type="fig"}B). Thus, analyses using crosses between B6 and MSM provide a higher resolution picture of locus-wide transcriptional activity together with insights into strand- and allele-specificity. Figure 1.Statistics of measurable SNP sites. (**A**) SNP sites were classified as exonic, intronic, or extra-genic. (**B**) SNP frequencies between B6 and other strains. The number of SNPs between B6 and MSM within the *Ube3a* locus (including the 5 kb up- and downstream regions) was counted. The SNP frequencies between B6 and the other strains were obtained from the Perlegen Mouse SNP catalogue ([@B21]).

Mono-allelic *Ube3a* expression associated with antisense transcription
-----------------------------------------------------------------------

Because the Illumina GoldenGate Assay is primarily designed for DNA-targeted genotyping experiments, pre-processing of the raw data derived from the transcriptome-targeted assay is required for accurate data analyses. Therefore, we used loess normalization to adjust signal intensity distribution of two channels and set threshold values based on the discriminant analysis method ([@B25]) to distinguish expressed sites from non-expressed sites and also to distinguish between the three different types of allelic expression (B6 mono-allelic, MSM mono-allelic and bi-allelic). Of the 1420 validated SNPs selected in the genotyping assays, 712 were used for detecting plus-strand expression and 708 were selected for detecting minus-strand expression. To examine the reproducibility of the results, we performed transcriptome-targeted assays for the two reciprocal hybrids B6xMSM (BM) and MSMxB6 (MB). Using this approach, we successfully generated a high-resolution strand- and allele-specific transcriptional landscape of the *Ube3a--Snurf*/*Snrpn* genomic region in brain and liver tissues ([Figure 2](#F2){ref-type="fig"}). Figure 2.Transcriptional landscape of the *Ube3a--Snurf*/*Snrpn* region. Status of strand- and allele-specific expression at *Ube3a--Snurf* locus in brain (**A**), and in liver (**B**). Each color indicates the expression status for every SNP site: B6 allele (magenta), MSM allele (green), both alleles (black) and non-expressed (light gray). Intensity value thresholds were set by the discriminant analysis method ([@B25]) to distinguish between expressed and non-expressed SNP sites and to distinguish between the three types of expressed allele. Assays were performed for both of the reciprocal hybrids, BM (B6xMSM) and MB (MSMxB6). The former indicates maternally contributed strain. Expression strands are distinguished by plus and minus. 'Plus' denotes those that detect the expression from plus-strand of the UCSC mouse genome assembly, whereas 'Minus' indicates the expression from minus-strand. Gene location is denoted in the upper panel: thick and narrow bars colored navy indicate exonic and intronic regions, respectively.

*Ube3a* is expressed from the maternal allele in a brain-specific manner ([@B27; @B28; @B29]), whereas *Snurf*/*Snrpn* shows paternal-specific gene expression in most tissues ([@B30]). We observed concordance trends, showing paternal-specific expression of *Snurf/Snrpn* in both brain and liver ([Figure 2](#F2){ref-type="fig"}). *Snurf*/*Snrpn* expression in the liver was restricted to the region as in the UCSC Known Genes Track ([@B31]), whereas it in the brain was widespread and included extra-genic regions of the *Snurf*/*Snprn* locus (from 100 kb upstream to 200 kb downstream). We did not obtain data for the ∼400 kb region between *Ube3a* and *Snurf*/*Snrpn* because of the lack of measurable SNPs to assay (see 'Materials and Methods' section); however, brain-specific paternal expression of the minus strand is likely to extend to the *Ube3a* peripheral region, which spans nearly 1 Mb of the genome and thus is antisense to *Ube3a*. This widespread transcription initiated from the upstream region of *Snurf*/*Snrpn* (producing *Ube3a-ATS*) has been described in the previous studies ([@B16],[@B17]). We also found that the transcription of the minus strand in liver was not widespread like in brain. Since the antisense transcription is only seen in brain where *Ube3a* shows mono-allelic expression, we suggest that the widespread transcription originated from *Snurf*/*Snrpn* locus might be involved in the control of mono-allelic *Ube3a* expression. This transcriptional status was detected for both of the reciprocal hybrids (BM and MB), indicating that the expression is parent-of-origin-specific.

Allelic imbalance of *Ube3a* expression in brain
------------------------------------------------

Our analysis can achieve locus-wide parallel genotyping of the expressed alleles and can also measure transcript abundance. Thus, the method can provide information not possible with assays targeting a small number of SNPs. As described, plus-strand expression of the *Ube3a* locus was observed specifically in the brain, consistent with known *Ube3a* expression pattern. However, we found that mono-allelic *Ube3a* expression was not detected along the entire locus; there is a shift from bi-allelic expression to mono-allelic expression within the locus. Circular binary segmentation (CBS) method ([@B32]) of the paternal and maternal signal intensity values identified a shift of allelic expression dividing the genomic locus into subregions showing bi-allelic expression and mono-allelic expression, respectively ([Supplementary Figure S2](http://nar.oxfordjournals.org/cgi/content/full/gkq1201/DC1)). The 'bi-allelic' region corresponds to about ∼25 kb region including the 1st and 2nd exon. The 'mono-allelic' region corresponds to the rest of the locus ([Figure 3](#F3){ref-type="fig"}A), and the transition appeared to occur in the middle of the 2nd intron. Such disparity was observed for both of the reciprocal hybrids. Individual SNP genotyping by strand-specific RT--PCR and the nucleotide sequencing also confirmed bi-allelic expression of the 5′ part of *Ube3a* in the brain tissue ([Figure 3](#F3){ref-type="fig"}B and C). The result led to the question whether this transition is caused by a reduction of paternal *Ube3a* expression in the latter half, or by an increase in maternal expression. To clarify these possibilities, we compared the intensity of allele-specific expression for the two segmental regions. We found that maternal expression in both reciprocal hybrids is notably increased in the 3′ part, whereas paternal expression does not differ between the two regions ([Figure 4](#F4){ref-type="fig"}). This result indicates that allelic imbalance of *Ube3a* expression is caused by an increased maternal expression in the latter half of the locus. Figure 3.Expressed alleles within the *Ube3a* locus. (**A**) Sequence analysis summary. SNP sites within the *Ube3a* locus for sequence analysis are indicated by arrows (thick lines and narrow lines indicate exonic and intronic regions, respectively). Expressed allele decisions are denoted for the plus and minus strand. Expression from plus strand means *Ube3a* sense expression. An orange mark denotes computationally estimated site which shows allelic balance alteration. (**B**) Sequence analysis results and decisions of expressed allele from plus strand for B6xMSM (upper) and MSMxB6 (lower). (**C**) Sequence analysis results and decisions of expressed allele from minus strand for B6xMSM (upper) and MSMxB6 (lower). Figure 4.Comparison of maternal and paternal expression of *Ube3a* in brain. Comparison of maternal and paternal expression of *Ube3a* in brain for the two regions, denoted a-1 and a-2, estimated by genomic segmentation analysis. (**A**) Maternal expression in the BM hybrid, (**B**) paternal expression in the BM hybrid, (**C**) maternal expression in the MB hybrid and (**D**) paternal expression in the MB hybrid. Statistical significance (*P*-values) was tested with the Wilcoxon test. The number of SNPs in the corresponding regions is indicated in the parenthesis. Dashed line indicates the threshold value to distinguish between expressed and non-expressed SNP sites.

We also observed a notable difference in paternal *Ube3a-ATS* expression in the vicinity of the *Ube3a* transcription start site. CBS showed clear disparity of paternal antisense expression between the two regions separated by *Ube3a* transcription start site ([Supplementary Figure S3](http://nar.oxfordjournals.org/cgi/content/full/gkq1201/DC1)). In the region upstream to the *Ube3a* transcription start site, antisense transcription still occurs from a paternal allele, but the ratio between the two alleles was significantly reduced compared to that from the *Ube3a* gene body. Indeed, paternal antisense expression was significantly higher in the *Ube3a* gene body than in the upstream region of *Ube3a* transcription start site (*P* = 2.0e--17, Wilcoxon test) ([Figure 5](#F5){ref-type="fig"}B and D). By comparison, maternal antisense transcript was hardly detected in the two regions ([Figure 5](#F5){ref-type="fig"}A and C). This finding suggests that *Ube3a*-ATS expression is preferentially suppressed in the vicinity of the *Ube3a* transcription start site. Figure 5.Comparison of maternal and paternal expression of *Ube3a-ATS.* Comparison of maternal and paternal expression of *Ube3a* in brain for the two regions separated by the transcription start site of *Ube3a*, denoted b-1 and b-2, estimated by genomic segmentation analysis. (**A**) maternal expression in the BM hybrid, (**B**) paternal expression in the BM hybrid, (**C**) maternal expression in the MB hybrid and (**D**) paternal expression in the MB hybrid. Statistical significance (*P*-values) was tested with the Wilcoxon test. The number of SNPs in the corresponding regions is indicated in the parenthesis. Dashed line indicates the threshold value to distinguish between expressed and non-expressed SNP sites.

DISCUSSION
==========

We used a highly parallel SNP genotyping system to successfully characterize the transcriptional landscape of the *Ube3a--Snurf*/*Snrpn* region. We used a combinatorial approach involving expressed allele genotyping together with genomic tiling-array-like high-resolution transcriptome analysis. SNP frequency of inter-subspecies hybrid is twice as high compared to other strain combination, enabling high-resolution analyses of allele-specific transcriptional activity within the megabase-wide region. Although we ourselves sequenced the MSM BAC contigs of the *Ube3a--Snurf/Snrpn* locus, the entire MSM genome sequences are now publicly available (<http://molossinus.lab.nig.ac.jp/msmdb/index.jsp>), thus facilitating the same analysis of the other gene loci.

We used cDNA targets representing whole transcriptome of both the poly(A)+ processed mRNA and non-poly(A) RNA population. We did this because of the unprocessed nascent-like nature of endogenous antisense transcription. In the case of *Air*, an antisense counterpart of *Igf2r*, transcription spans a 100-kb genomic region, and the transcript appears to be unspliced ([@B7],[@B33]). Also, recent micorarray-based transcriptome analyses and expression analyses of individual genes showed that endogenous antisense transcripts in mammals tend to be poly(A)-negative ([@B26],[@B34]). Thus, SNP genotyping targeting the whole transcriptome is essential to full understanding of locus-wide competition between sense and antisense transcripts.

One of the interesting observations from our analysis is that brain-specific maternal expression of *Ube3a* occurs only from the second half part of the locus, but not from the first half. This 'allelic-shift' in *Ube3a* expression is the consequence of the marked difference in maternal *Ube3a* expression between the two regions (5′ and 3′ half part). Although this observation might reflect the existence of an alternative maternal-specific variant that lacks first and second exons, we could not find any evidences supporting the existence of such variant(s) in the public datasets; there are no enrichment of histone H3K4 tri-methylation active mark ([@B35],[@B36]) or CAGE tags that indicates transcription start site in the second intron (data not shown). No ESTs that aligned in the vicinity are found as well. Meanwhile, there is a possibility that 'allelic-shift' might reflect the situation in the nuclear transcriptome, because our analysis uses cDNA target generated from the total RNA, not mere poly(A)-selected RNA. As we also detected considerable level of poly(A)-minus *Ube3a* sense and antisense transcript with heterogeneous nature in its molecular weight by northern hybridization (data not shown), allelic imbalance of *Ube3a* expression might be regulated in a competitive manner with antisense transcription in the nucleus.

In humans, strand-specific RT--PCR analysis has previously suggested that another maternally transcribed unit exists within the downstream region to *UBE3A* ([@B37]). In addition, alternatively terminated variants as well as several poly-adenylation signals have been identified for the *UBE3A* locus ([@B38]). Since we observed predominant maternal expression not only from the *Ube3a* genic region, but also from the extra-genic downstream region, murine *Ube3a* might express maternal transcripts from its downstream region.

Because we used whole brain as a source of RNA, our observations reflect the situation in the mixture of brain tissue cell types, consists of neurons and glial cells. Previous studies using primary brain cell cultures revealed that expression of *Ube3a* is parental-of-origin-specific in neurons, but bi-allelic in glial cells ([@B39],[@B40]). Thus, our findings using the entire brain transcriptome can only provide an 'average' of *Ube3a* expression for the two major brain cell types. Indeed, we found that a certain level of *Ube3a* expression was detected not only from the maternal allele but also from the paternal allele ([Figure 4](#F4){ref-type="fig"}B and D). This is most likely the result of the bi-allelic nature of *Ube3a* expression in glial cells.

Our results for the expression of the antisense transcript of *Ube3a* (*Ube3a-ATS*) most likely reflect expression in neurons because *Ube3a-ATS* is not expressed in glial cells ([@B39],[@B40]). We did not investigate the molecular basis for the reduction in *Ube3a-ATS* expression, but our observations suggest that overlap of the antisense transcript with the transcription start site or a CpG island that covers the *Ube3a* transcription start site might be essential for repression of paternal *Ube3a* expression. It has shown previously that abnormal antisense transcription generated by genetic mutation induces DNA methylation in the promoter region of the *HBA2* locus, resulting in repression of gene expression ([@B41]). Silencing of paternal *Ube3a* expression might also be induced by similar mechanism. Intriguingly, a slight, but not statistically significant (*P* \> 0.05, Wilcoxon test), upregulation of maternal *Ube3a-ATS* is observed from the upstream region of the transcription start site of *Ube3a* ([Figure 5](#F5){ref-type="fig"}A and C). This suggests that leakage of maternal antisense transcription near the promoter might arise as a result of *Ube3a* expression from the maternal allele. Another experimental approach is therefore required to examine the molecular mechanism underlying the control of gene expression mediated by *Ube3a-ATS*. Overall, our data clearly showed that allele-specific expression of *Ube3a* is variable depending on the genomic position.

Recently, several studies using high-throughput technology have identified many examples of mono-allelically expressed genes ([@B1; @B2; @B3; @B4; @B5]), including random mono-allelic genes and imprinted genes, with some of these associated with sense and antisense transcription. In addition, many imprinted genes (or imprinted regions) show expression of the antisense transcript ([@B6]). Although high-throughput sequencing also can generate the data that distinguish strand- and allele-specificity of the transcripts, it requires huge number of sequence reads to retrieve sufficient depth for each SNP sites, and also requires target enrichment step to analyze particular gene locus. Here, we demonstrated that array-based approach of megabase-wide region can provide high-resolution insight into allele-specific sense and antisense transcriptional dynamics, which is the foundation for understanding the mechanisms of antisense-mediated gene regulation. The highly parallel SNP genotyping approach we undertook in this study is also applicable to the analysis of immunoprecipitated DNA, including methylated DNA, and histone modifications. We have now succeeded to establish B6--MSM hybrid ES cells and its neuronal differentiation *in vitro* (Kohama, C. *et al*., manuscript in preparation). Analyses targeting immunopreciptated DNA coupled with the transcriptome analysis of the hybrid ES cell differentiation have the potential to provide a deeper understanding of the association between epigenetic regulation and strand-specific transcription.
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